Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Xiang, Xianyuan"" wg kryterium: Autor


Wyświetlanie 1-14 z 14
Tytuł :
White matter aging drives microglial diversity.
Autorzy :
Safaiyan S; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.
Besson-Girard S; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.
Kaya T; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.
Cantuti-Castelvetri L; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.
Liu L; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.
Ji H; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.
Schifferer M; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.
Gouna G; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.
Usifo F; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany.
Kannaiyan N; Department of Psychiatry, Ludwig-Maximilians-Universität, 80336 Munich, Germany.
Fitzner D; Department of Neurology, University of Göttingen, 37075 Göttingen, Germany.
Xiang X; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität Munich, 81377 Munich, Germany.
Rossner MJ; Department of Psychiatry, Ludwig-Maximilians-Universität, 80336 Munich, Germany.
Brendel M; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, 81377 Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), 81377 Munich, Germany.
Gokce O; Institute for Stroke and Dementia Research, University Hospital of Munich, LMU Munich, 81377 Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), 81377 Munich, Germany. Electronic address: .
Simons M; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), 81377 Munich, Germany. Electronic address: .
Pokaż więcej
Źródło :
Neuron [Neuron] 2021 Apr 07; Vol. 109 (7), pp. 1100-1117.e10. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Microglia/*physiology
White Matter/*cytology
White Matter/*growth & development
Aging/physiology ; Alzheimer Disease/genetics ; Animals ; Apolipoproteins E/genetics ; Demyelinating Diseases/pathology ; Gene Expression Regulation ; Gray Matter/cytology ; Gray Matter/growth & development ; Immunohistochemistry ; Membrane Glycoproteins/biosynthesis ; Membrane Glycoproteins/genetics ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microglia/ultrastructure ; Myelin Sheath/metabolism ; Receptors, Immunologic/biosynthesis ; Receptors, Immunologic/genetics ; Sequence Analysis, RNA ; Signal Transduction/physiology ; Single-Cell Analysis
Czasopismo naukowe
Tytuł :
The Alzheimer's disease-associated protective Plcγ2-P522R variant promotes immune functions.
Autorzy :
Takalo M; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Wittrahm R; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Wefers B; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), München, Munich, Germany.; Institute of Developmental Genetics, Helmholtz Zentrum München, Munich, Germany.
Parhizkar S; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Jokivarsi K; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Kuulasmaa T; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Mäkinen P; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Martiskainen H; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Wurst W; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), München, Munich, Germany.; Institute of Developmental Genetics, Helmholtz Zentrum München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Xiang X; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Marttinen M; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.; Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Poutiainen P; Center of Diagnostic Imaging, Department of Cyclotron and Radiopharmacy, Kuopio University Hospital, Kuopio, Finland.
Haapasalo A; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Hiltunen M; Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland. .
Haass C; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), München, Munich, Germany. .; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany. .; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. .
Pokaż więcej
Źródło :
Molecular neurodegeneration [Mol Neurodegener] 2020 Sep 11; Vol. 15 (1), pp. 52. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region.
Autorzy :
Schlepckow K; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Monroe KM; Denali Therapeutics Inc., South San Francisco, CA, USA.
Kleinberger G; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Cantuti-Castelvetri L; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Parhizkar S; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Xia D; Denali Therapeutics Inc., South San Francisco, CA, USA.
Willem M; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Werner G; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Pettkus N; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Brunner B; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Sülzen A; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Nuscher B; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Hampel H; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Xiang X; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.; Graduate School of Systemic Neuroscience, Ludwig-Maximilians-Universität München, Munich, Germany.
Feederle R; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Helmholtz Center Munich, German Research Center for Environmental Health, Institute for Diabetes and Obesity, Core Facility Monoclonal Antibody Development, Munich, Germany.
Tahirovic S; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Park JI; Denali Therapeutics Inc., South San Francisco, CA, USA.
Prorok R; Denali Therapeutics Inc., South San Francisco, CA, USA.
Mahon C; Denali Therapeutics Inc., South San Francisco, CA, USA.
Liang CC; Denali Therapeutics Inc., South San Francisco, CA, USA.
Shi J; Denali Therapeutics Inc., South San Francisco, CA, USA.
Kim DJ; Denali Therapeutics Inc., South San Francisco, CA, USA.
Sabelström H; Denali Therapeutics Inc., South San Francisco, CA, USA.
Huang F; Denali Therapeutics Inc., South San Francisco, CA, USA.
Di Paolo G; Denali Therapeutics Inc., South San Francisco, CA, USA.
Simons M; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Institute of Neuronal Cell Biology (TUM-NZB), Munich, Germany.
Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA.
Haass C; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Pokaż więcej
Źródło :
EMBO molecular medicine [EMBO Mol Med] 2020 Apr 07; Vol. 12 (4), pp. e11227. Date of Electronic Publication: 2020 Mar 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Microglia*/pathology
Multiple Myeloma*
Antibodies, Monoclonal/*pharmacology
Membrane Glycoproteins/*immunology
Receptors, Immunologic/*immunology
Amyloid beta-Peptides ; Animals ; Cell Line, Tumor ; Female ; Macrophages ; Mice ; Rats ; Rats, Wistar
Czasopismo naukowe
Tytuł :
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
Autorzy :
Xiang X; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.; Graduate School of Systemic Neuroscience, Ludwig- Maximilians- University Munich, Munich, Germany.
Piers TM; Department of Neuroinflammation, Cell Signalling Lab, University College London Institute of Neurology, WC1N 1PJ, London, UK.
Wefers B; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Institute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Zhu K; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Mallach A; Department of Neuroinflammation, Cell Signalling Lab, University College London Institute of Neurology, WC1N 1PJ, London, UK.
Brunner B; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Kleinberger G; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Song W; Department of Immunology and Pathology, Washington University in St. Louis, St. Louis, MO, USA.
Colonna M; Department of Immunology and Pathology, Washington University in St. Louis, St. Louis, MO, USA.
Herms J; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Wurst W; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Institute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Technische Universität München-Weihenstephan, 85764, Neuherberg/Munich, Germany.
Pocock JM; Department of Neuroinflammation, Cell Signalling Lab, University College London Institute of Neurology, WC1N 1PJ, London, UK.
Haass C; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany. .; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. .; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. .
Pokaż więcej
Źródło :
Molecular neurodegeneration [Mol Neurodegener] 2018 Sep 06; Vol. 13 (1), pp. 49. Date of Electronic Publication: 2018 Sep 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Predisposition to Disease*
Alzheimer Disease/*genetics
Membrane Glycoproteins/*genetics
Receptors, Immunologic/*genetics
Alzheimer Disease/metabolism ; Animals ; Brain/metabolism ; Disease Models, Animal ; Genetic Variation/genetics ; Humans ; Mice, Transgenic ; Microglia/metabolism ; RNA Splicing/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł :
Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6.
Autorzy :
Zhu K; German Center for Neurodegenerative Diseases, Munich, Germany; Center for Neuropathology and Prion Research, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany.
Xiang X; Graduate School of Systemic Neuroscience, Ludwig-Maximilians University Munich, Munich, Germany.
Filser S; German Center for Neurodegenerative Diseases, Munich, Germany; Center for Neuropathology and Prion Research, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany.
Marinković P; German Center for Neurodegenerative Diseases, Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany.
Dorostkar MM; German Center for Neurodegenerative Diseases, Munich, Germany; Center for Neuropathology and Prion Research, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany.
Crux S; German Center for Neurodegenerative Diseases, Munich, Germany; Center for Neuropathology and Prion Research, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany.
Neumann U; Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.
Shimshek DR; Neuroscience, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.
Rammes G; Department of Anesthesiology, Klinikum rechts der Isar, Munich, Germany.
Haass C; German Center for Neurodegenerative Diseases, Munich, Germany; Biomedical Center, Biochemistry, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany.
Lichtenthaler SF; German Center for Neurodegenerative Diseases, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany; Institute for Advanced Study, Technical University of Munich, Munich, Germany; Neuroproteomics, Klinikum rechts der Isar, Munich, Germany.
Gunnersen JM; Department of Anatomy and Neuroscience, University of Melbourne, Melbourne, Victoria, Australia.
Herms J; German Center for Neurodegenerative Diseases, Munich, Germany; Center for Neuropathology and Prion Research, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany. Electronic address: .
Pokaż więcej
Źródło :
Biological psychiatry [Biol Psychiatry] 2018 Mar 01; Vol. 83 (5), pp. 428-437. Date of Electronic Publication: 2016 Dec 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Amyloid Precursor Protein Secretases/*metabolism
Aspartic Acid Endopeptidases/*metabolism
Dendritic Spines/*metabolism
Hippocampus/*metabolism
Long-Term Potentiation/*physiology
Nerve Tissue Proteins/*metabolism
Neuronal Plasticity/*physiology
Amyloid Precursor Protein Secretases/antagonists & inhibitors ; Animals ; Aspartic Acid Endopeptidases/antagonists & inhibitors ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Transgenic
Czasopismo naukowe
Tytuł :
The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.
Autorzy :
Kleinberger G; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Brendel M; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Mracsko E; NORD Discovery & Translational Area, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Wefers B; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Groeneweg L; NORD Discovery & Translational Area, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Xiang X; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Focke C; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Deußing M; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Suárez-Calvet M; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Mazaheri F; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Parhizkar S; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Pettkus N; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Wurst W; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Institute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Technische Universität München, Freising-Weihenstephan, Germany.
Feederle R; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Helmholtz Center Munich, German Research Center for Environmental Health, Institute for Diabetes and Obesity, Core Facility Monoclonal Antibody Development, Munich, Germany.
Bartenstein P; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Mueggler T; NORD Discovery & Translational Area, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Arzberger T; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany.; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität München, Munich, Germany.
Knuesel I; NORD Discovery & Translational Area, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Rominger A; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Haass C; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany .; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Pokaż więcej
Źródło :
The EMBO journal [EMBO J] 2017 Jul 03; Vol. 36 (13), pp. 1837-1853. Date of Electronic Publication: 2017 May 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation, Missense*
Perfusion*
Brain/*pathology
Frontotemporal Dementia/*pathology
Glucose/*metabolism
Membrane Glycoproteins/*genetics
Microglia/*physiology
Receptors, Immunologic/*genetics
Animals ; Disease Models, Animal ; Gene Knock-In Techniques ; Humans ; Immunohistochemistry ; Magnetic Resonance Imaging ; Mice ; Mutant Proteins/genetics ; Positron-Emission Tomography
Czasopismo naukowe
Tytuł :
TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance.
Autorzy :
Xiang X; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-University Munich, Munich, Germany Graduate School of Systemic Neuroscience, Ludwig-Maximilians-University Munich, Munich, Germany.
Werner G; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-University Munich, Munich, Germany.
Bohrmann B; Roche Pharmaceutical Research and Early Development NORD Discovery & Translational Area, Roche Innovation Center Basel, Basel, Switzerland.
Liesz A; Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Mazaheri F; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Capell A; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-University Munich, Munich, Germany.
Feederle R; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany Helmholtz Center Munich, German Research Center for Environmental Health, Institute for Diabetes and Obesity Core Facility Monoclonal Antibody Development, Munich, Germany.
Knuesel I; Roche Pharmaceutical Research and Early Development NORD Discovery & Translational Area, Roche Innovation Center Basel, Basel, Switzerland.
Kleinberger G; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-University Munich, Munich, Germany Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Haass C; Biomedical Center (BMC), Biochemistry, Ludwig-Maximilians-University Munich, Munich, Germany Munich Cluster for Systems Neurology (SyNergy), Munich, Germany German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany .
Pokaż więcej
Źródło :
EMBO molecular medicine [EMBO Mol Med] 2016 Sep 01; Vol. 8 (9), pp. 992-1004. Date of Electronic Publication: 2016 Sep 01 (Print Publication: 2016).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Phagocytosis*
Amyloid/*metabolism
Membrane Glycoproteins/*deficiency
Neuroglia/*immunology
Receptors, Immunologic/*deficiency
Animals ; Cells, Cultured ; Mice, Inbred C57BL ; Mice, Knockout ; Neuroglia/physiology
Czasopismo naukowe
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies